A communication from the University of Massachusetts Medical School (see Section 43(f) of Chapter 75 of the General Laws) submitting a report of the activities of the MassBiologics Laboratories for fiscal year 2025

This bill (HD 5256) is a procedural submission requiring MassBiologics (a division of the University of Massachusetts Chan Medical School) to provide its annual report for fiscal year 2025, as mandated by Chapter 75, Section 43(f) of Massachusetts General Laws. The report details MassBiologics' activities, including financials, patents, licensing agreements (like those for Synagis and CytoGam), and future financial projections. It does not create new laws or policies but fulfills a routine state reporting requirement for this public health laboratory. This is the 28th annual submission under this statute, covering FY2025 (July 2024-June 2025).